Phosphodiesterase type 5 inhibitors related hearing impairment: a real world study based on the FDA adverse event reporting system
Crossref DOI link: https://doi.org/10.1038/s41598-024-60493-w
Published Online: 2024-04-28
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Zhang, Xunyan
Xia, Lu
Yang, Qiang
Tang, Pingxiu http://orcid.org/0009-0001-1789-3269
Text and Data Mining valid from 2024-04-28
Version of Record valid from 2024-04-28
Article History
Received: 24 January 2024
Accepted: 23 April 2024
First Online: 28 April 2024
Competing interests
: The authors declare no competing interests.